-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Research in acute decompensated heart failure: challenges and opportunities
Brian C Hiestand
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Ethical issues in adult oncology randomized clinical trials
Erika P Hamilton, Jeffrey M Peppercorn
Clinical Trail Outcomes: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Parkinsons disease: will therapy move beyond dopaminergic medication?
Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation